Comprehensive Clinical Trial Supply Services

Clinical trial supply refers to the planning, management, packaging, storage, distribution, tracking, and resupply of all investigational products (IMPs) and related components required to conduct a clinical trial. Its goal is to ensure that the right drug, placebo, comparator, and supporting materials reach the right patient, at the right site, at the right time. At Sharp, our team runs it all as a single integrated clinical trial supply service.

It comprises all activities and players involved in manufacturing, packaging, labeling, storing, distributing, tracking, and resupplying investigational products from production through to patient dosing in a clinical trial. Our team coordinates every step across 30+ depots in the Americas, EMEA, and APAC.

Yes. Sharp offers support across clinical development, sterile manufacturing, and commercial packaging under a single quality system, so you can scale from first-in-human to launch without having to qualify a new vendor.

Clinical trials typically scale up when patient enrolment accelerates, additional sites or countries are activated, new cohorts are introduced, or studies progress from early- to late-phase development. As these changes increase demand for the investigational product, our team continuously adjusts supply forecasts, inventory levels, packaging volumes, and distribution strategies to ensure uninterrupted patient dosing.

By combining proactive planning, continuous supply oversight, flexible logistics strategies, and integrated operational execution across the supply chain, our team helps ensure a steady supply of IMP.

Yes. We provide in-house EU- and UK-Qualified Person release, including QP certification, batch release, and QP oversight, so you can benefit from multi-region trial support through a single partner.